ISHL13
Join us at the International Symposium on Hodgkin Lymphoma (ISHL13)
BeiGene will attend ISHL13 in Cologne. We hope to see you there in person!
ISHL13 offers clinicians around the world the opportunity to stay current with the latest advances in biology, translational and clinical research, diagnostics, and treatment of Hodgkin Lymphoma.
ISHL13 begins with an educational session on B-cell malignancies, followed shortly by the BeiGene-sponsored satellite symposium, which will also focus on B-cell lymphomas.
Please join our BeiGene-sponsored Satellite Symposium: The evolving role of BTKis in the treatment of B-cell lymphomas
The BeiGene-sponsored Satellite Symposium will be held on October 26th, 13.15-14.45 in the Gürzenich Hall Conference Center. Add the Satellite Symposium to your calendar!
This symposium, chaired by Prof. Christian Buske, will present the evolving landscape of Bruton tyrosine kinase inhibitors (BTKis) in treating B-cell lymphomas. Prof. Catherine Thieblemont will present data on the use of BTKis in follicular lymphoma and marginal zone lymphoma, Prof. Buske will follow with new data in Waldenström’s macroglobulinemia, and Dr. David Lewis will present updates in mantle cell lymphoma. Finally, Dr. Anna Maria Frustaci will discuss future developments in the treatment of B-cell lymphomas, such as the use of chimeric degradation activation compounds and B-cell lymphoma-2 inhibitors. Following the presentations, there will be a panel discussion and an opportunity for the audience to ask questions to the faculty.
Webcasts of the Satellite Symposia
After the congress, you will find the webcast and slides of the Satellite Symposium in the Congress Resources section of our website.